Jiangsu Jiujiujiu Technology Rmb7 billion acquisition of Shaanxi Bicon Pharmaceutical

16/12/2015

Private acquisition

Value:

$ 7 billion

Status:

Completed

Date:

16/12/2015

Overview:

Jiangsu Jiujiujiu Technology Company has acquired 100% equities of Shaanxi Bicon Pharmaceutical by reverse IPO, for Rmb7 billion.
Jiangsu Jiujiujiu Technology Company develops and manufactures pharmaceuticals and pesticides in China and abroad.
Shaanxi Bicon Pharmaceutical Company manufactures and sells pharmaceuticals internationally.

Hanna Rae Choi - Researcher

Jurisdiction:

China

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

China

Industry sector:

Pharmaceuticals and life sciences

Firm:

Chen & Co Law Firm

Party: Jiangsu Jiujiujiu Technology (Acquirer)

Related deals